Dal Poggetto John 4
4 · Sonoma Pharmaceuticals, Inc. · Filed Jul 9, 2026
Research Summary
AI-generated summary of this filing
Sonoma (SNOA) Controller John Dal Poggetto Receives RSU Award
What Happened John Dal Poggetto, Controller of Sonoma Pharmaceuticals, was granted 7,500 restricted stock units (RSUs) on July 9, 2026. The Form 4 reports an acquisition-type transaction (Code A) at $0.00 per unit — the RSUs are a contingent right to receive common stock upon vesting rather than an immediate stock purchase or sale.
Key Details
- Transaction date: 2026-07-09; reported on Form 4 filed the same date (Accession 0001683168-26-005418).
- Instrument: 7,500 restricted stock units (derivative award); acquisition price shown as $0.00.
- Vesting: RSUs vest on the third anniversary of the grant date, or upon a change of control (per filing footnotes).
- Purpose: Awarded for services performed (per filing footnotes).
- Shares owned after transaction: Not specified in the provided filing.
- Timeliness: Filing shows the report date same as the transaction date; no late filing flag indicated.
Context RSUs are a grant of a contingent right to receive shares in the future once vesting conditions are met; they do not represent immediately tradable shares. This is an equity compensation award (neutral by itself) rather than an insider purchase or sale.
Insider Transaction Report
Form 4
Dal Poggetto John
Controller
Transactions
- Award
Restricted Stock Units
[F1][F3][F2]2026-07-09+7,500→ 32,750 totalExercise: $0.00→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock.
- [F2]The RSUs vest on the third anniversary of the grant date, or upon change of control.
- [F3]The RSUs were awarded and granted to Mr. Dal Poggetto for services performed.
Signature
/s/ John Dal Poggetto|2026-07-09